This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) to Purchase Specialty Pharmacy PANTHERx Rare
by Zacks Equity Research
Centene (CNC) to buy specialty pharmacy PANTHERx Rare to penetrate the specialty drug market and cater to patients with complex situations.
Here's Why You Should Hold Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) remains well-poised for growth on the back of a strong Medicare business and adequate cash generation capabilities.
Humana (HUM) Boosts Value-Based Care With New PCF Model
by Zacks Equity Research
Humana (HUM) enhances its value-based healthcare model to ease the financial pressure on members and add to its capabilities.
Humana (HUM) Ties Up to Boost Presence Across West Virginia
by Zacks Equity Research
Humana (HUM) partners with St. Mary's Medical Center, which intends to offer improved health outcomes across West Virginia.
Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare
by Zacks Equity Research
Humana (HUM) to acquire rest of iCare's shares from CFI to extend its Medicare business in Wisconsin.
Humana (HUM), St. Luke's Health Tie Up for Enhanced Healthcare
by Zacks Equity Research
Humana (HUM) teams up with St. Luke's Health Partners to provide better medical care in Idaho.
UnitedHealth's (UNH) Solid Earnings View Buoys Investor Hopes
by Zacks Equity Research
UnitedHealth (UNH) provides an upbeat earnings guidance for 2020 and 2021, prompted by strong growth in its UnitedHealthcare and Optum segments.
Humana (HUM) Enhances Value-Based Care With Vancouver Clinic
by Zacks Equity Research
Humana (HUM) intends to strengthen value-based relationship with Vancouver Clinic, which is likely to offer improved health outcomes across Clark County.
3 Healthcare Stocks to Keep Gaining From Telehealth Services
by Srijita Guha
Amid the coronavirus pandemic, we pick three healthcare stocks that are poised to grow on the back of virtual care facilities.
Magellan Health's (MGLN) Arm Enhances Mental Health Solutions
by Zacks Equity Research
Magellan Health's (MGLN) behavioral and specialty health subsidiary introduces programs to help people deal with mental health illnesses amid festivities.
Humana (HUM) Enhances Its Services in Washington Counties
by Zacks Equity Research
Humana (HUM) recently adds to its services in Washington. Eligible members in Benton, Walla Walla and Franklin counties will now get more healthcare options.
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
by Zacks Equity Research
Banking on strategic measures and growing revenues, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Humana (HUM) to Offer MA Plans in Massachusetts for First Time
by Zacks Equity Research
Humana's (HUM) Medicare Advantage plans to make a debut in Massachusetts for fortifying the company's foothold in the state.
Centene (CNC) Marketplace Product Undergoes Technology Upgrade
by Zacks Equity Research
Centene's (CNC) Marketplace product - Ambetter undertakes technology improvements for benefiting members and new enrollees.
Humana (HUM) Inks Deal to Better Serve Members in Kansas Area
by Zacks Equity Research
Humana (HUM) partners Prime Healthcare to mete out better healthcare facilities to members residing in the Kansas region.
Centene (CNC) Acquires Apixio, Boosts Data Analytics Portfolio
by Zacks Equity Research
Centene (CNC) inks deal to acquire Apixio for availing enhanced AI technology solutions and digitizing its administrative activities.
Humana (HUM), Northwell Tie Up for Better Health Outcome
by Zacks Equity Research
Humana (HUM) partners with Northwell to provide improved healthcare services in the New York metropolitan region.
Magellan's (MGLN) Q3 Earnings Top Estimates, Decline Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) third-quarter results benefit from strong specialty pharmacy operations, partly offset by escalating expenses.
Universal Health's (UHS) Q3 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect higher revenues and lower expenses.
Ensign Group's (ENSG) Q3 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q3 results reflect healthy revenues and its robust Transitional and Skilled Services segment.
Molina Healthcare's (MOH) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results reflect higher revenues and membership.
Community Health's (CYH) Earnings Beat in Q3, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) third-quarter earnings gain from lower costs. However, the same is offset to some extent due to soft admissions.
Here is Why Growth Investors Should Buy Centene (CNC) Now
by Zacks Equity Research
Centene (CNC) could produce exceptional returns because of its solid growth attributes.
Anthem (ANTM) Q3 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q3 earnings benefit from strong Medicaid and Medicare businesses as well as solid contributions from its Commercial & Specialty Business and Government Business.
Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.